Phil Walter/Getty Images
There's a slight slowing in the amount of healthcare M&A right now, even though 2018 started out strong.
The healthcare industry has historically been one of the most active sectors for deals. But a recent research report from Morgan Stanley said that analysts think high valuations of healthcare companies as well as a wealth of readily available funding for biotechs are limiting the number of takeovers.
Here are the top 10 healthcare companies Morgan Stanley analysts predict are most likely to receive tender offers in the next 12 months. Morgan Stanley used a proprietary quantitative model to make its predictions. It also excluded stocks that have been the subject of takeover rumors.
